Biblio

Author Title [ Type(Desc)] Year
Filters: Author is Rodems, Steven  [Clear All Filters]
Journal Article
Li R, Pradhan M, Xu M, Baskfield A, Farkhondeh A, Cheng Y-S, Beers J, Zou J, Liu C, Might M, et al. Generation of an induced pluripotent stem cell line (TRNDi002-B) from a patient carrying compound heterozygous p.Q208X and p.G310G mutations in the NGLY1 gene. Stem Cell Res. 2018;34:101362.
Brooks BM, Pradhan M, Cheng Y-S, Gorshkov K, Farkhondeh A, Chen CZ, Beers J, Liu C, Baumgaertel K, Rodems S, et al. Generation of an induced pluripotent stem cell line (TRNDi031-A) from a patient with Alagille syndrome type 1 carrying a heterozygous p. C312X (c. 936 T > A) mutation in JAGGED-1. Stem Cell Res. 2021;54:102447.
Pavlinov I, Farkhondeh A, Yang S, Xu M, Cheng Y-S, Beers J, Zou J, Liu C, Might M, Rodems S, et al. Generation of two gene corrected human isogenic iPSC lines (NCATS-CL6104 and NCATS-CL6105) from a patient line (NCATS-CL6103) carrying a homozygous p.R401X mutation in the NGLY1 gene using CRISPR/Cas9. Stem Cell Res. 2021;56:102554.
Pradhan M, Farkhondeh A, Cheng Y-S, Xu M, Beers J, Zou J, Liu C, Might M, Rodems S, Baumgärtel K, et al. An induced pluripotent stem cell line (NCATS-CL9075) from a patient carrying compound heterozygote mutations, p.R390P and p.L318P, in the NGLY1 gene. Stem Cell Res. 2021;54:102400.
Yang S, Cheng Y-S, Li R, Pradhan M, Hong J, Beers J, Zou J, Liu C, Might M, Rodems S, et al. An induced pluripotent stem cell line (TRNDi010-C) from a patient carrying a homozygous p.R401X mutation in the NGLY1 gene. Stem Cell Res. 2019;39:101496.
Farkhondeh A, Li R, Gorshkov K, Chen KG, Might M, Rodems S, Lo DC, Zheng W. Induced pluripotent stem cells for neural drug discovery. Drug Discov Today. 2019.